Notice Number: NOT-CA-19-026

Key Dates
Release Date : February 19, 2019

RFA-CA-19-008

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform potential applicants about a correction in RFA-CA-19-008 "The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratories (U24 Clinical Trial Not Allowed)"

The correction applies to the sentence below in the R&R Budget section of Section IV.2. Content and Form of Application Submission:

The sentence to be corrected currently reads:

In projecting cost, applicants should assume that each of the two ETCTN U24 awardees will be required to process/analyze approximately 15,000 PK specimens per year.

This sentence is corrected to read:

In projecting cost, applicants should assume that each of the two ETCTN U24 awardees will be required to process/analyze approximately 7,500 PK specimens per year (i.e., with the combined total for both awardees amounting to approximately 15,000 specimens/year).

All other aspects of RFA-CA-19-008 remain unchanged.

Inquiries

Please direct all inquiries to:

S. Percy Ivy, MD
National Cancer Institute (NCI)
Telephone: 240-276-6565
Email: to [email protected]